S&P 500
(-0.34%) 5 018.39 points
Dow Jones
(0.23%) 37 903 points
Nasdaq
(-0.33%) 15 605 points
Oil
(0.61%) $79.48
Gas
(1.24%) $1.956
Gold
(0.81%) $2 329.70
Silver
(0.29%) $26.83
Platinum
(1.33%) $967.60
USD/EUR
(-0.01%) $0.933
USD/NOK
(-0.04%) $11.03
USD/GBP
(-0.08%) $0.798
USD/RUB
(0.27%) $93.51

Echtzeitaktualisierungen für Fresenius SE & Co KGaA [FRE.DE]

Börse: XETRA Sektor: Healthcare Industrie: Medical Care Facilities
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-07)

Expected move: +/- 0.00%

Zuletzt aktualisiert30 Apr 2024 @ 17:35

1.05% 27.97

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 17:35):

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed...

Stats
Tagesvolumen 1.08M
Durchschnittsvolumen 1.12M
Marktkapitalisierung 15.75B
EPS €0 ( 2024-02-20 )
Nächstes Ertragsdatum ( €0.700 ) 2024-05-07
Last Dividend €0.920 ( 2023-05-18 )
Next Dividend €0 ( N/A )
P/E 44.40
ATR14 €0.0130 (0.05%)

Volumen Korrelation

Lang: 0.29 (neutral)
Kurz: -0.15 (neutral)
Signal:(44.885) Neutral

Fresenius SE & Co KGaA Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Fresenius SE & Co KGaA Korrelation - Währung/Rohstoff

The country flag -0.20
( neutral )
The country flag -0.12
( neutral )
The country flag 0.00
( neutral )
The country flag -0.06
( neutral )
The country flag -0.44
( neutral )

Fresenius SE & Co KGaA Finanzdaten

Annual 2023
Umsatz: €22.30B
Bruttogewinn: €5.06B (22.68 %)
EPS: €-1.050
FY 2023
Umsatz: €22.30B
Bruttogewinn: €5.06B (22.68 %)
EPS: €-1.050
FY 2022
Umsatz: €40.84B
Bruttogewinn: €10.73B (26.26 %)
EPS: €2.44
FY 2021
Umsatz: €37.52B
Bruttogewinn: €10.31B (27.48 %)
EPS: €3.26

Financial Reports:

No articles found.

Fresenius SE & Co KGaA Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0.920
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Fresenius SE & Co KGaA Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.12 - average (70.83%) | Divividend Growth Potential Score: 2.36 - Decrease likely (52.84%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €0.512 2000-06-09
Last Dividend €0.920 2023-05-18
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 25 --
Total Paid Out €12.51 --
Avg. Dividend % Per Year 0.00% --
Score 2.02 --
Div. Sustainability Score 6.12
Div.Growth Potential Score 2.36
Div. Directional Score 4.24 --
Next Divdend (Est)
(2025-03-19)
€0.964 Estimate 3.15 %
Dividend Stability
0.25 Very Poor
Dividend Score
2.02
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PAT.DE Ex Dividend Junior 2023-05-26 Sporadic 0 0.00%
ALD.DE Ex Dividend Knight 2023-08-10 Quarterly 0 0.00%
HAW.DE Ex Dividend Junior 2023-06-13 Annually 0 0.00%
SAP.DE Ex Dividend Knight 2023-05-12 Annually 0 0.00%
BST.DE Ex Dividend Junior 2023-09-14 Sporadic 0 0.00%
KBX.DE Ex Dividend Knight 2023-05-08 Annually 0 0.00%
TNE5.DE Ex Dividend Junior 2023-12-12 Semi-Annually 0 0.00%
DEF.DE Ex Dividend Knight 2023-07-24 Annually 0 0.00%
MSF.DE Ex Dividend Knight 2023-08-16 Quarterly 0 0.00%
47T.F Ex Dividend Knight 2023-09-06 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.01871.500-0.374-0.561[0 - 0.5]
returnOnAssetsTTM-0.01311.200-0.437-0.525[0 - 0.3]
returnOnEquityTTM-0.02981.500-1.443-2.16[0.1 - 1]
payoutRatioTTM-2.07-1.000-10.0010.00[0 - 1]
currentRatioTTM1.3420.8008.296.63[1 - 3]
quickRatioTTM0.7290.800-0.419-0.335[0.8 - 2.5]
cashRatioTTM0.2451.5009.7510.00[0.2 - 2]
debtRatioTTM0.350-1.5004.17-6.26[0 - 0.6]
interestCoverageTTM2.531.000-0.174-0.174[3 - 30]
operatingCashFlowPerShareTTM7.912.007.3610.00[0 - 30]
freeCashFlowPerShareTTM5.902.007.0510.00[0 - 20]
debtEquityRatioTTM0.833-1.5006.67-10.00[0 - 2.5]
grossProfitMarginTTM0.2331.0009.459.45[0.2 - 0.8]
operatingProfitMarginTTM0.05541.000-0.892-0.892[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2811.0009.559.55[0.2 - 2]
assetTurnoverTTM0.7020.8008.656.92[0.5 - 2]
Total Score6.12

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-26.521.000-2.780[1 - 100]
returnOnEquityTTM-0.02982.50-0.927-2.16[0.1 - 1.5]
freeCashFlowPerShareTTM5.902.008.0310.00[0 - 30]
dividendYielPercentageTTM3.291.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM7.912.007.3610.00[0 - 30]
payoutRatioTTM-2.071.500-10.0010.00[0 - 1]
pegRatioTTM0.4681.500-0.2100[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1401.0008.990[0.1 - 0.5]
Total Score2.36

Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.